TY  - GEN
AU  - Fakhouri,Fadi
AU  - Hourmant,Maryvonne
AU  - Campistol,Josep M
AU  - Cataland,Spero R
AU  - Espinosa,Mario
AU  - Gaber,A Osama
AU  - Menne,Jan
AU  - Minetti,Enrico E
AU  - Provôt,François
AU  - Rondeau,Eric
AU  - Ruggenenti,Piero
AU  - Weekers,Laurent E
AU  - Ogawa,Masayo
AU  - Bedrosian,Camille L
AU  - Legendre,Christophe M
TI  - Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial
SN  - 1523-6838
PY  - 2017///0531
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Atypical Hemolytic Uremic Syndrome
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Remission Induction
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1053/j.ajkd.2015.12.034
ER  -